Cite
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model.
MLA
Axelsson Raja, Anna, et al. “Ablation of Lysophosphatidic Acid Receptor 1 Attenuates Hypertrophic Cardiomyopathy in a Mouse Model.” Proceedings of the National Academy of Sciences of the United States of America, vol. 119, no. 28, July 2022, p. e2204174119. EBSCOhost, https://doi.org/10.1073/pnas.2204174119.
APA
Axelsson Raja, A., Wakimoto, H., DeLaughter, D. M., Reichart, D., Gorham, J., Conner, D. A., Lun, M., Probst, C. K., Sakai, N., Knipe, R. S., Montesi, S. B., Shea, B., Adam, L. P., Leinwand, L. A., Wan, W., Choi, E. S., Lindberg, E. L., Patone, G., Noseda, M., … Ho, C. Y. (2022). Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model. Proceedings of the National Academy of Sciences of the United States of America, 119(28), e2204174119. https://doi.org/10.1073/pnas.2204174119
Chicago
Axelsson Raja, Anna, Hiroko Wakimoto, Daniel M DeLaughter, Daniel Reichart, Joshua Gorham, David A Conner, Mingyue Lun, et al. 2022. “Ablation of Lysophosphatidic Acid Receptor 1 Attenuates Hypertrophic Cardiomyopathy in a Mouse Model.” Proceedings of the National Academy of Sciences of the United States of America 119 (28): e2204174119. doi:10.1073/pnas.2204174119.